CVS is now selling a rival generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated before Congress because of its soaring cost to consumers.
CVS is now selling a rival generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated before Congress because of its soaring cost to consumers. Matt Rourke AP
CVS is now selling a rival generic version of Mylan’s EpiPen at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated before Congress because of its soaring cost to consumers. Matt Rourke AP

Business

January 12, 2017 10:12 AM

CVS puts out generic competitor to EpiPen at a 6th the price

Suggested for you

  Comments  

Videos

Editor's Choice Videos